| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.04% | -2.18% | +48.66% | +88.78% | 1,001B | |
| -0.25% | -3.40% | +48.94% | +63.45% | 642B | |
| +0.95% | +0.42% | +16.94% | +72.79% | 451B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 340B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 263B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 247B | |
| -0.74% | -13.09% | +34.40% | +45.19% | 207B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 197B | |
| -0.67% | -4.61% | +22.21% | +86.97% | 180B | |
| Average | -0.48% | -5.53% | +20.81% | +41.28% | 391.82B | |
| Weighted average by Cap. | -0.24% | -4.65% | +30.24% | +56.04% |
Employees
4
Sector
Pharmaceuticals
